These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10964310)

  • 1. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
    Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
    Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
    Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
    Bohuslavizki KH; Klutmann S; Sonnemann U; Thoms J; Kröger S; Werner JA; Mester J; Clausen M
    Laryngorhinootologie; 1999 Aug; 78(8):445-9. PubMed ID: 10488465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
    AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
    Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
    Yabuki K; Tsukuda M; Horiuchi C; Taguchi T; Nishimura G
    Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1785-92. PubMed ID: 20814690
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
    Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
    Dale E; Moan JM; Osnes TA; Bogsrud TV
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
    Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
    Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
    Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
    Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
    Stoeckli SJ; Mosna-Firlejczyk K; Goerres GW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):411-6. PubMed ID: 12634970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.
    Johansen J; Buus S; Loft A; Keiding S; Overgaard M; Hansen HS; Grau C; Bundgaard T; Kirkegaard J; Overgaard J
    Head Neck; 2008 Apr; 30(4):471-8. PubMed ID: 18023031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
    Périé S; Talbot JN; Monceaux G; Grahek D; Kerrou K; Montravers F; St Guily JL
    Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):755-60. PubMed ID: 10961809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
    de Bree R
    Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1653-5. PubMed ID: 20827553
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.